FTXH vs. IHE
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and IHE (iShares U.S. Pharmaceuticals ETF) are both Health & Biotech Equities funds - FTXH tracks the Nasdaq U.S. Smart Pharmaceuticals Index while IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index. Both are passively managed. Over the past 5 years, FTXH returned 8.33%/yr vs 10.57%/yr for IHE. A 0.76 correlation means they provide meaningful diversification when combined. FTXH charges 0.60%/yr vs 0.42%/yr for IHE.
Performance
FTXH vs. IHE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FTXH achieves a 7.62% return, which is significantly lower than IHE's 9.33% return.
FTXH
- 1D
- 2.50%
- 1M
- 3.66%
- YTD
- 7.62%
- 6M
- 9.20%
- 1Y
- 39.54%
- 3Y*
- 12.33%
- 5Y*
- 8.33%
- 10Y*
- —
IHE
- 1D
- 2.69%
- 1M
- 3.48%
- YTD
- 9.33%
- 6M
- 12.42%
- 1Y
- 43.59%
- 3Y*
- 18.33%
- 5Y*
- 10.57%
- 10Y*
- 7.97%
FTXH vs. IHE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 7.62% | 24.15% | 2.98% | -1.41% | 2.55% | 6.14% | 11.73% | 22.13% | -9.51% | 19.44% |
IHE iShares U.S. Pharmaceuticals ETF | 9.33% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
Correlation
The correlation between FTXH and IHE is 0.88, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.88 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.86 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.85 |
Correlation (All Time) Calculated using the full available price history since Sep 23, 2016 | 0.76 |
The correlation between FTXH and IHE shifts across timeframes, from 0.76 (all time) to 0.88 (1 year), reflecting how their relationship changes across market environments.
FTXH vs. IHE - Sectors Allocation Comparison
Sectors
FTXH
IHE
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FTXH
IHE
Basic Materials
FTXH
-
IHE
-
Communication Services
FTXH
-
IHE
-
Consumer Cyclical
FTXH
-
IHE
-
Consumer Defensive
FTXH
-
IHE
-
Energy
FTXH
-
IHE
-
Financial Services
FTXH
-
IHE
-
Industrials
FTXH
-
IHE
-
Real Estate
FTXH
-
IHE
-
Technology
FTXH
-
IHE
-
Utilities
FTXH
-
IHE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTXH vs. IHE — Risk / Return Rank
FTXH
IHE
FTXH vs. IHE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FTXH | IHE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.22 | ||
| Sortino ratioReturn per unit of downside risk | -0.27 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.43 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 5.32 | 5.17 | +0.15 |
| Martin ratioReturn relative to average drawdown | 15.35 | 15.58 | -0.23 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FTXH | IHE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.32 | 2.54 | -0.22 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | 0.65 | -0.14 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.44 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.51 | -0.12 |
Drawdowns
FTXH vs. IHE - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for FTXH and IHE.
Loading charts...
Drawdown Indicators
| FTXH | IHE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.11% | -38.20% | +6.09% |
Max Drawdown (1Y)Largest decline over 1 year | -7.47% | -8.47% | +1.00% |
Max Drawdown (3Y)Largest decline over 3 years | -19.51% | -15.92% | -3.59% |
Max Drawdown (5Y)Largest decline over 5 years | -19.51% | -16.03% | -3.48% |
Max Drawdown (10Y)Largest decline over 10 years | — | -29.59% | — |
Current DrawdownCurrent decline from peak | -0.45% | -0.18% | -0.27% |
Average DrawdownAverage peak-to-trough decline | -5.84% | -7.92% | +2.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.58% | 2.81% | -0.23% |
Volatility
FTXH vs. IHE - Volatility Comparison
The current volatility for First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 5.38%, while iShares U.S. Pharmaceuticals ETF (IHE) has a volatility of 6.04%. This indicates that FTXH experiences smaller price fluctuations and is considered to be less risky than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FTXH | IHE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.38% | 6.04% | -0.66% |
Volatility (6M)Calculated over the trailing 6-month period | 11.96% | 12.70% | -0.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.14% | 17.26% | -0.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.34% | 16.28% | +0.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.43% | 18.07% | +0.36% |
FTXH vs. IHE - Expense Ratio Comparison
FTXH has a 0.60% expense ratio, which is higher than IHE's 0.42% expense ratio.
Dividends
FTXH vs. IHE - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.19%, less than IHE's 1.61% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.19% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% | 0.00% |
IHE iShares U.S. Pharmaceuticals ETF | 1.61% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
Frequently Asked Questions
FTXH and IHE have a correlation of 0.88, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IHE has higher volatility (6.04%) compared to FTXH (5.38%). In terms of maximum drawdown, FTXH dropped -32.11% vs IHE's -38.20%.
On 5-year performance, IHE leads with 10.57% vs 8.33% for FTXH. On fees, IHE is cheaper at 0.42% per year. On volatility, FTXH has been the lower-risk option at 5.38%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IHE has performed better with a 10.57% return vs 8.33%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IHE is cheaper with a 0.42% expense ratio, compared with 0.60% for FTXH.
IHE has the higher dividend yield at 1.61%, compared with 1.19% for FTXH.
FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while IHE tracks Dow Jones U.S. Select Pharmaceuticals Index. They also come from different issuers: First Trust and iShares. Their fees differ too: 0.60% for FTXH and 0.42% for IHE.
IHE currently has the higher Sharpe Ratio (2.54 vs 2.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FTXH and IHE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer